LOS ANGELES, April 24, 2025 /PRNewswire/ -- Blue Zones Health, a primary care model proven to improve patient health outcomes
VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the
VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the
MOUNT PROSPECT, Ill., April 24, 2025 /PRNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) is pleased to announce
MOUNT PROSPECT, Ill., April 24, 2025 /PRNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) is pleased to announce
Draft notification sets binding targets for 282 high-emission entities from 2025, introduces penalties for non-compliance.
Draft notification sets binding targets for 282 high-emission entities from 2025, introduces penalties for non-compliance.
The company will continue to operate within the power sector and their asset expansion focus is in transmission – both
The company will continue to operate within the power sector and their asset expansion focus is in transmission – both